Objectives To audit the use of intrauterine balloon tamponade for the management of massive postpartum haemorrhage and compare outcomes with those documented in the literature.
Introduction
Postpartum haemorrhage (PPH) is defined as an estimated blood loss of more than 500 mL after delivery and occurs with a frequency of around 5%. 1 An additional definition for PPH after caesarean delivery arbitrarily refers to a blood loss of over 1000 mL. 2 Firstline treatment options for PPH include conservative management with uterotonic drugs (oxytocin or prostaglandins); second-line therapy includes uterine packing, external compression with uterine sutures, and selective devascularisation by ligation or embolisation of the uterine artery. [3] [4] [5] [6] [7] Failure of conservative management is often deemed to warrant hysterectomy, which may be associated with further blood loss and additional morbidity. 8 Although the use of uterotonic drugs and various conservative measures are included in various authoritative protocols, the actual utilisation rates and timing of these procedures vary widely from centre to centre. 9 Recently, intrauterine balloon tamponade has been quite widely used as a second-line procedure in the management of massive PPH, and has become an integral part of the "HEMOSTASIS" management algorithm widely advocated in the UK. 2, 10 Various types of balloon catheters have been reported in the literature, including the Bakri balloon, the Roush balloon, the SengstakenBlakemore tube, or Foley catheters adapted for intrauterine tamponade. 11 In Hong Kong, intrauterine balloon tamponade for the management of massive PPH was only introduced as part of obstetric training in the last few years. The current case series describes its use in the management of massive PPH that continued despite medical therapy. All obstetric training and service units in Hong Kong are run under the auspices of the Hong Kong New knowledge added by this study • Bakri intrauterine balloon tamponade is effective in the management of postpartum haemorrhage arising from uterine atony as well as placenta praevia.
• When used as the first-line surgical procedure after failed medical treatment, it can reduce recourse to hysterectomy.
Implications for clinical practice or policy
• Intrauterine balloon tamponade should be adopted as part of the management for massive postpartum haemorrhage in local obstetric units.
Hospital Authority (HA). Accordingly, we set out to retrospectively review a single centre's experience in treating PPH by balloon tamponade. A review of the literature was then conducted to compare our results with those reported worldwide.
Methods
The Bakri intrauterine balloon catheter (Cook Medical, Bloomington [IN] , US) was the only intrauterine balloon device available in our department. A retrospective review of all cases with severe PPH following delivery in our unit during the 18-month period from January 2011 to June 2012 was performed, based on a comprehensive obstetric database currently in use in all HA obstetric units. Specific codings for "obstetric tamponade of the uterus and vagina" and "insertion of therapeutic device into uterus" were identified from the HA clinical management system. Cases of severe PPH with an estimated blood loss exceeding 1.5 L were also identified from the Labour Ward registry. The case notes of each of these patients were reviewed manually to verify whether intrauterine balloon tamponade techniques had been used in their management. All identified cases where intrauterine balloon tamponade had been used or attempted were then reviewed in detail for the mode of delivery and intrapartum complications. Information was also retrieved about the cause of the PPH, the sequence of treatments, estimated total blood loss, any complications resulting from different therapeutic manoeuvres, and clinical outcomes. The relevant international literature was then reviewed to compare our results with those of others using intrauterine balloon tamponade for the same purpose.
The procedure for insertion of the Bakri balloon was similar to that originally described by the inventor, 12 though vaginal packing was not routinely performed unless there was evidence of slippage or prolapse of the balloon through the cervix. The distal end of the catheter was taped to the patient's thigh but weights were not used. While ultrasound visualisation of balloon placement was reported in the literature, 13 this was not considered necessary in our series. When the balloon was inserted during a caesarean section, the distal end of the balloon shaft was passed through the cervical opening with an assistant pulling the end per vagina. The use of a traction suture to keep the balloon in the uterus was not undertaken.
14 If bleeding was arrested after balloon inflation, the balloon tamponade was continued for 24 hours, after which, the deflation was performed, either in two stages or in a single stage (depending on the attending obstetrician's discretion). All patients had an indwelling Foley catheter to monitor urine output, and broadspectrum antibiotics were used for prophylaxis.
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Results
In all, there were 8006 deliveries over the review period. The frequency of primary PPH with an estimated blood loss exceeding 500 mL was 3.4% (n=270). The frequency of massive PPH with an estimated blood loss exceeding 1.5 L was 0.4% (n=35). Among the 35 patients with massive PPH, there were 19 patients in whom the Bakri balloon catheter was used. Within the same period, there were six peripartum hysterectomies, two of which involved attempted use of the Bakri balloon catheter and were included in this case series. Of the other 16 cases with massive PPH, four were managed with the addition of oxytoxic agents alone, eight had uterine compression sutures (of which six were successful while two failed and underwent hysterectomy), one patient had surgical ligation of the internal iliac artery on one side and the uterine artery on the other side, and another had radiological embolism of the uterine arteries. Two others had placenta accreta not amenable to complete delivery for which balloon tamponade was not considered an option and hysterectomy was performed. These 16 cases that did not involve the use of the balloon catheter in the management were excluded from the subsequent analysis and discussion.
All the identified cases of PPH that involved use of the Bakri balloon catheter failed initial medical management with oxytoxics, including bolus syntometrine, syntocinon bolus and infusion, and intramuscular carboprost injections in 16 (84%) of our 19 cases. Carboprost injections were not used in three patients as the bleeding was considered not due to significant uterine atony. Two patients had caesarean sections for major placenta praevia and balloon tamponade was used primarily for compression of the lower-segment placental bed. In the third, brisk bleeding was encountered from the posterior placental bed during caesarean section, and transabdominal placement of the balloon was used to achieve tamponade.
The mode of delivery was vaginal in 7/19 (37%) The most common aetiology for PPH was uterine atony (15/19), followed by major placenta praevia (4/19). Estimated intra-operative blood losses ranged from 1500 mL to 6320 mL (median, 2000 mL). All patients received blood product transfusions, and documented disseminated intravascular coagulopathy was present in at least nine (47%). One patient had a cardiac arrest shortly after continuous heavy bleeding after Bakri balloon catheter insertion, but was successfully resuscitated and underwent an immediate laparotomy and peripartum hysterectomy. All these patients were admitted to the Intensive Care Unit (ICU) after insertion of the Bakri balloon. Their stays in the ICU ranged from 24 hours to 4 days. In our series of 19 patients, major organ damage was not encountered and there was no other long-term morbidity (Table 1 ).
In the majority of cases (18/19), the Bakri balloon was the first modality of treatment after medical management; in the remaining patient it was used after failure of compression sutures. In this patient with placenta praevia, B-Lynch sutures were applied followed by closure of the uterine wound, but the sutures broke following ongoing manipulations and a Bakri balloon was therefore inserted vaginally. Additional treatment modalities were carried out in four cases, including two that entailed uterine arterial embolisation and two for whom peripartum hysterectomy was carried out. In all four patients, continuous bleeding exceeded 500 mL (drained via a catheter), thus prompting further management. The overall success rate in preventing hysterectomy with the Bakri balloon catheter as the only procedure was 15/19 (79%), and its success rate in conjunction with other procedures was 17/19 (89%). Factor VIIa was not used in this case series.
There were no major complications arising from the use of the Bakri balloon catheter. In two patients, the balloon was punctured after insertion during the application of haemostatic stitches. Both patients were delivered by caesarean section for major placenta praevia. In one patient, the catheter was inserted transabdominally through the uterine wound. The catheter was partially inflated during uterine wound closure and then more so after closure of the uterine incision. The balloon was punctured while attempting to add more haemostatic sutures around the uterine wound, and so a second balloon catheter was introduced vaginally. In the second case, the Bakri balloon was inserted vaginally after the uterine wound was closed post-caesarean section. Again, the balloon was punctured subsequent to haemostatic sutures to the uterine wound, and a second balloon was reinserted vaginally.
Discussion
The concept of uterine packing has long been utilised for controlling severe uterine haemorrhage, but Bakri et al 12 first proposed using a specifically designed intrauterine balloon catheter, which he did in a series of five women with haemorrhage from low-lying placentae or cervical pregnancies. Subsequently, various types of balloon catheters, including the Foley catheter, 15 Sengstaken-Blakemore tube, 16 Rusch balloon, and condom catheters have been adapted for similar clinical scenarios. 11 At present, the Bakri balloon remains the only balloon product specifically designed for the control of PPH. So far, there are few absolute contra-indications to its use to achieve tamponade. The manufacturer of the Bakri catheter has included uterine anomalies, arterial bleeding, and purulent infection of the genital tract as indications for its use, which have also been adopted in various authoritative guidelines. 17 While the original Bakri balloon was described for placenta praevia, apparently, such tamponade techniques were also effective in other cases of PPH, such as uterine atony. Using a SengstakenBlakemore balloon catheter as a diagnostic and therapeutic 'tamponade test' in a series of 16 cases, it was shown to effectively stop bleeding in 14 (88%) of patients for the purpose of avoiding surgery. 3 The authors remarked that this 'diagnostic' test rapidly identifies patients with PPH that might otherwise warrant a laparotomy. 3 In another series of 23 cases of PPH that was unresponsive to medical therapy, 18 the bleeding was controlled in 18 (90%) of 20 patients in whom balloon catheters were properly placed. The two others were deemed to require a hysterectomy, despite proper placement. Technical difficulties led to failure of catheter placement in the remaining three. However, when only cases of uterine atony were analysed, the success rate was 100% (11/11).
Other reports have focused on the management of placenta praevia/accreta. One series concentrated on evaluating a protocol for conservative measures to treat placenta praevia/accreta over a period of 15 months. Preventive radiological catheterization of the descending aorta was followed by caesarean delivery, use of Affronti endouterine square haemostatic sutures, and placement of an intrauterine Bakri balloon in conjunction with B-Lynch sutures. A total of nine cases were analysed, and all were successfully treated without resorting to embolisation or hysterectomy. 19 In another recent series of 37 patients undergoing caesarean section for placenta praevia/ low-lying placenta, it was reported that out of 33 deemed not to require hysterectomy for accreta, 10 (30%) warranted a Sengstaken-Blakemore balloon to control bleeding, despite medical treatment. Apparently all of them were successfully treated without additional procedures. 20 According to the literature, intrauterine balloon tamponade can be deployed concurrently with other conservative techniques. Notably, the successful application of the 'uterine sandwich' using uterine compression sutures in conjunction with the Bakri balloon tamponade has been described in two patients with massive haemorrhage 21, 22 and in a series of five women with PPH due to uterine atony. 23 A series of 11 cases with placenta praevia or uterine atony using Hayman sutures combined with the Bakri balloon have also been described, 24 with no major complications and a 100% success rate. Another series of 20 cases was published recently, in which the Bakri balloon was used as the treatment of first choice in 20 cases. 25 Of these, 12 were successfully managed with the balloon alone but six warranted the balloon and B-Lynch sutures, while two finally had a hysterectomy. 25 Major complications have been reported following the use of balloon catheters. Thus, caesarean scar dehiscence has been associated with intrauterine balloon tamponade placement after a second-trimester dilatation and evacuation. 26 Ten weeks following application of uterine compression sutures combined with Rusch intrauterine balloon tamponade, uterine necrosis ensued. 27 The authors therefore suggested looking out for uterine blanching when applying such balloon/sandwich techniques. Intraluminal pressure was objectively measured while using the Bakri balloon in two patients, and showed that it did not exceed the patient's systolic pressure when tamponade becomes established. 28 Thus, when used alone, the intrauterine balloon is unlikely to give rise to uterine necrosis, but if used in combination with compression sutures, the risk could well increase.
The efficacy of intrauterine balloon catheters for the treatment for PPH appears similar to other forms of management. In a systematic review of various conservative management modalities for this condition, estimated cumulative outcomes showed success rates of 91% for arterial embolisation, 84% for balloon tamponade, 92% for uterine compression sutures, and 85% for iliac artery ligation or uterine devascularisation.
Nevertheless, the authors commented that balloon tamponade was the least invasive and most rapidly implemented, and that it seemed logical to use it as the first step of management in suitable cases.
29
At present, there are little direct data to compare and evaluate the efficacy of different second-line conservative management modalities for PPH. Understandably, true randomised controlled trials would be difficult to carry out in such life-threatening clinical scenarios presenting as a dire emergency. A 
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fair comparison of the different treatment modalities would also be difficult to carry out, as specific treatments may be indicated in specific situations. For instance, intrauterine balloon tamponade may be particularly indicated for massive PPH after a vaginal delivery, while uterine compression sutures tend to be used (with or without balloon tamponade) after caesarean delivery. Recombinant factor VIIa may be more strongly indicated in the presence of disseminated intravascular coagulation when conventional transfusion of blood products fail to reverse the process, while radiological methods for uterine artery embolisation can depend on the availability of expertise of an interventional specialist. It is therefore apparent that the use of these different modalities should be flexible and geared to the aetiology of the PPH and feasible clinical responses tailored to the condition of the patient concerned during different stages of the emergency.
A literature search on case series of at least five patients describing the use of intrauterine balloon tamponade for the control of PPH going back three decades showed that the mean success rate in preventing hysterectomy was around 88% (Table  2) . 3, 12, [14] [15] [16] [18] [19] [20] [23] [24] [25] [29] [30] [31] [32] [33] [34] [35] The success rate in our series was consistent with this figure. Apparently, there were no significant differences in success rates when different types of balloon catheters are used. We have no experience of concurrently using the Bakri balloon together with compression sutures, which could further enhance success rates. Nevertheless, the data here show that intrauterine balloon tamponade can be used effectively for the management of massive PPH in our local setting.
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